Lobbying Filing Details

Total Spending

$270,000

Activities

4

Lobbyists

2

Gov't Entities

9

Filing Information
Filing UUID:
c8536344-fcbc-4781-8fb4-6e16f2bae694
Type:
Q2 - 2nd Quarter - Report
Period:
2025 - 2nd Quarter (Apr 1 - June 30)
Date Posted:
July 21, 2025 at 10:14 PM
Income:
$0
Expenses:
$270,000
Expense Method:
A
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Jason D. Kaune, Attorney & Agent for Filer
Registrant
BIOMARIN PHARMACEUTICAL INC.

Develops and commercializes biopharmaceuticals.

San Rafael, California
Client
BIOMARIN PHARMACEUTICAL INC.
California, United States of America
Lobbying Activities (4)
Activity 1
Health Issues

HR 1262: GIVE KIDS A CHANCE ACT OF 2025; PROVISIONS RELATED TO RARE PEDIATRIC DISEASE PRIORITY REVIEW VOUCHER PROGRAM REAUTHORIZATION S 932: GIVE KIDS A CHANCE ACT OF 2025; PROVISIONS RELATED TO RARE PEDIATRIC DISEASE PRIORITY REVIEW VOUCHER PROGRAM REAUTHORIZATION GENERAL DISCUSSIONS REGARDING INFLATION REDUCTION ACT AND ORPHAN DRUGS GENERAL DISCUSSIONS REGARDING ORPHAN DRUG ACT GENERAL DISCUSSIONS REGARDING GENETIC SCREENING AND NEWBORN SCREENING

Lobbyists (2)
  • KATHRYN LOWELL
  • JOHN EDWARD GREISSING
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 2
Medicare/Medicaid

H.R. 1: ONE BIG BEAUTIFUL BILL ACT; PROVISIONS RELATED TO TITLE VII, SUBTITLE B H.R. 946: ORPHAN Cures Act; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS OF THE BILL S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS OF THE BILL S. 1637: MEDICAID VBPS FOR PATIENTS (MVP) Act; ALL PROVISIONS S. 1862: ORPHAN Cures Act; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING MEDICAID DRUG REBATE PROGRAM GENERAL DISCUSSIONS REGARDING FOREIGN DRUG REFERENCE PRICING

Lobbyists (1)
  • JOHN EDWARD GREISSING
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 3
Tariff (miscellaneous tariff bills)

GENERAL DISCUSSIONS REGARDING TARIFFS ON PHARMACEUTICALS

Lobbyists (1)
  • JOHN EDWARD GREISSING
Government Entities (3)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Commerce, Dept of (DOC)
Activity 4
Taxation/Internal Revenue Code

GENERAL DISCUSSIONS REGARDING ORPHAN DRUG TAX CREDIT

Lobbyists (1)
  • JOHN EDWARD GREISSING
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 10, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.